Publications Rikus (H) Knegtering, MD PhD. Update May 2010. Publications in the Dutch language have an English translation added.

Publications Rikus (H) Knegtering, MD PhD. Update May 2010. Publications in the Dutch language have an English translation added. 2010 Vercammen A., Knegtering H., den Boer H., Liemburg E., Aleman A (2010). Auditory hallucinations in schizophrenia are associated with reduced functional connectivity of the temporo-parietal area. Biological psychiatry. 15;67(10):912-8. Epub 7 jan 2010. doi:10.1016/j.biopsych.2009.11.017 Westenbroek JM., Ouwehand J., Sytema, S., Wiersma D., Knegtering H (2010). Menstrual disorders in schizophrenia, possible causes and consequences (submitted). De Lange J, Kuipers M, Knegtering H (2010). Does the Critical Flicker Fusion Threshold distinguish patients with schizophrenia from healthy controls? (submitted). Knegtering H., Oolders H., Ruisink M., Moolen van der A.E.G.M (2010). Depot antipsychotica anno 2010 (Depot antipsychotics anno 2010). Nederlands Tijdschrift voor Geneeskunde (accepted). Jiawan V.C.R, Arends J., Slooff C., Knegtering H (2010). Medicamenteuze interventies bij negatieve symptomen bij patiënten met schizofrenie (Pharmacological interventions for negative symptoms in patients with schizophrenia). Nederlands Tijdschrift voor Psychiatrie (In press) Wolters H.A. (2010). Desired and undesired effects of antipsychotic treatment from a patients perspective: the psychometric evaluation of a self rating instrument. University of Groningen, The Netherlands. PhD Thesis. (http://irs.ub.rug.nl/ppn/32377184x) (supervision D. Wiersma (promotor), H. Knegtering (co-promotor). Boer de M.K., Bous J., Sytema S., Moolen van der AEGM, Hamamura T., Wilffert B., Bous, J., Wiersma D., Knegtering H. (2010). A randomized open-label comparison of the impact of aripiprazole versus risperidone on sexual functioning (RAS study) (submitted). Castelein S., Bruggeman R., van Busschbach JT., Knegtering H., van der Gaag M., Wiersma D. Predictors of successful participation in peer support groups for psychosis (submitted). Liemburg E., Aleman A., Knegtering H (2010). Biologische achtergrond van negatieve symptomen bij schizofrenie (The biological background of negative symptoms in schizophrenia). In: Kenniscentrum schizofrenie boekenreeks (accepted). Dlabac-De Lange JJ., Knegtering H., Aleman A (2010). Rapid Transcranial Magnetic Stimulation (r- TMS) for negative and cognitive symptoms in schizophrenia, a meta-analyses. J Clin Psychiatry. 71(4):411-8. Feb 23. [Epub ahead of print]. Castelein S., Bruggeman R., van Busschbach JT., van der Gaag M., Stant D., Knegtering H., Wiersma D (2010). Lotgenotengroepen voor mensen met psychosen: een gerandomiseerde en gecontroleerde studie (Pear support groups for people suffering from a psychotic illness, a randomized controlled trial). Geschreven op verzoek van het Nederlands Tijdschrift voor Geneeskunde (Written on request of the Dutch Journal of Medecine) (In press). Liemburg E., Swart M., Curcic-Blake B., Knegtering H., Aleman A. Altered resting state connectivity of the self-reflection network in alexithymia (submitted). Lako I., Taxis K., Bruggeman R., Wiersma D., Slooff C (2010). The prevalence of depressive symptoms and the effectiveness of antidepressants in routine clinical practice of schizophrenia. Schiz Res. Special Issue 2 nd Biennial Schizophrenia International Research Conference, Florence 10-14 April pp 534-535. Liemburg EJ., Vercammen A., Knegtering H., Curcic-Blake B., Aleman A (2010). Altered connectivity in auditory and attention systems of schizophrenia patients with auditory hallucinations. Schiz Res. Special Issue 2 nd Biennial Schizophrenia International Research Conference, Florence 10-14 April pp351. Castelein R., Bruggeman R., van Busschbach JT., Knegtering H., van der Gaag M., Wiersma D., (2010). Predictors of successful participation in peer groups support for psychosis. Poster 2e Schizophrenia International Research Society, Florence 10-14 April pp 276-277. Bais L., Hoekert M., Links TP., Knegtering H., Aleman A (2010). Brain asymmetry for emotional prosody in Klinefelter s syndrome. Causal relations investigated with TMS. Poster 2e Schizophrenia International Research Society, Florence 10-14 April pp 233-234. Van der Meer L., Pijnenborg M., Nolen WA., Knegtering H., Aleman A (2010). The neural basis of self reflecting processing in schizophrenia patients: an fmri study. Schiz Res. Special Issue 2 nd Biennial Schizophrenia International Research Conference, Florence 10-14 April. pp 231 Vercammen A., Knegtering H., Liemburg EJ., Boer JA., Aleman A (2010). Functional connectivity of the temporo-parietal region in schizophrenia: Effects of rtms treatment of auditory

hallucinations. J Psychiatr Res. Feb 25. [Epub ahead of print] Vercammen A., Knegtering H., Bruggeman R., Aleman A (2010). Subjective Loudness and Reality of Auditory Verbal Hallucinations and Activation of the Inner Speech Processing Network. Schizophr Bull. May 15;67(10):912-8. Feb 17. [Epub ahead of print] Modinos G., Vercammen A., Mechelli A., Knegtering H. Aleman A. (2009). Structural covariance in the hallucinating brain: a voxel-based morphometry. In: Gemma Modinos Comellas. Imaging the vulnerable brain, functional and structural MRI in psychosis proneness. PhD thesis Univeristy of Groningen The Netherlands. 26-april 2010; pp 119-126. 2009 Wolters HA., Wiersma D., van den Bosch RJ., Knegtering H. Effects and side effects of antipsychotic treatment in schizophrenia: pros and cons of available self-rating scales. Schizophr Res. 2009 Jul;112(1-3):114-8. [Epub 2009 Apr 23]. Smid HGOM., Westenbroek JM., Bruggeman R., Knegtering H., van den Bosch RJ (2009). Abnormal externally-guided movement preparation in early-onset schizophrenia is associated with impaired selective attention to external input. Psychiatry Res. 2009 Nov 30;170(1):75-81. [Epub 2009 Sep 16]. Stant D., Castelein S., Bruggeman R., van Busschbach JT., van der Gaag M., Knegtering H., Wiersma D., Economical aspects of peer support groups for psychosis. Community Ment Health J. 2009 Mar 24. [Epub ahead of print]. Wolters HA., Wiersma D., van den Bosch RJ., Knegtering H. Effects and side effects of antipsychotic treatment in schizophrenia: pros and cons of available self-rating scales. Abstract for ICOSR congress San Diego (Schizophrenia Research, special issue, March 2009, oral presentation). Stant D., Castelein S., Bruggeman R., van Busschbach JT., van der Gaag M., Knegtering H., Wiersma D., Economical aspects of peer support groups for psychosis. In: Castelein S. Guided peer support groups for psychosis, a randomized trial. PhD thesis University of Groningen March 11-2009, page 49-66. (http://irs.ub.rug.nl/ppn/316715158) Castelein S., Bruggeman R., Busschbach JT., Knegtering H., van der Gaag M., Wiersma D. Predictors of successful participation in peer support groups for psychosis. In: Castelein S. Guided peer support groups for psychosis, a randomized trial. PhD thesis University of Groningen March 11-2009, page 67-80. (http://irs.ub.rug.nl/ppn/316715158) Castelein S., Bruggeman R., Busschbach JT., van der Gaag M., Stant D., Knegtering H., Wiersma D. Th effectiveness of peer support groups in psychosis: A randomized controlled trial. In: Castelein S. Guided peer support groups for psychosis, a randomized trial. PhD thesis University of Groningen March 11-2009, page 29-48. (http://irs.ub.rug.nl/ppn/316715158) Knegtering H., Ouwehand J., Sytema, S., Wiersma D. (2009). Menstrual disorders in schizophrenia, possible causes and consequences. Abstract for ICOSR congress San Diego (Schizophrenia Research, special issue, March 2009, poster). Knegtering H., Bous J. Psychofarmaca en seksueel functioneren, theorie en praktijk (Psychopharmacology and sexual functioning). Congres bijdrage en gepubliceerd in het congresboek voor de vereniging voor Gynaecologie en Obstetrie. 5 maart 2009. Bolle G., Griffioen T., Knegtering H (2009). Seksuologie en psychiatrie (Sexuology and psychiatry). In: Gijs L., Gianotten WL, Vanweesenbeek I., Weijenborg PTM (red). Seksuologie 2 e herzien druk (Dutch Textbook of Sexuology, revised version).houten Bohn Staflleu en van Loghum. 515-533. Modinos G., Vercammen A., Mechelli A., Knegtering H., Aleman A. Structural covariance in the hallucinating brain: A voxel-based morphometry study. Journal of Psychiatry and Neuroscience, Nov;34(6):465-9. Knegtering H., Bous, J., Sytema S., Wiersma D (2009). A randomized open-label comparison of the impact of aripiprazole versus risperidone on sexual functioning (RAS study). Report for the Rob Giel Research Center, Lentis Groningen and Bristol Myers Squibb. August 2009. Modinos G., Vercammen A., Mechelli A., Knegtering H. Aleman A. (2009). Structural covariance in the hallucinating brain: a voxel-based morphometry. In: Vercammen A. PhD Thesis: Cognitive and neural processes of auditory-verbal hallucinations in schizophrenia. page 97-106. (http://irs.ub.rug.nl/ppn/321676343). Vercammen A. Cognitive and neural processes of auditory-verbal hallucinations in schizophrenia. PhD Thesis University of Groningen, The Netherlands (http://irs.ub.rug.nl/ppn/321676343) Vercammen A., Knegtering H., Bruggeman R., Aleman A (2009). Perceptual characteristics of auditory-verbal hallucinations are associated with activation of the inner speech processing network. In: Vercammen A. PhD Thesis: Cognitive and neural processes of auditory-verbal

hallucinations in schizophrenia, page 107-122. (http://irs.ub.rug.nl/ppn/321676343) Vercammen A., Knegtering H., Bruggeman R., Westenbroek JM., Jenner JA., Slooff CJ., Wunderink L., Aleman A (2009). Effects of bilateral repetitive Transcranial Magnetic Stimulation (rtms) on treatment resistant auditory-verbal hallucinations in schizophrenia: a randomized controlled trial. In: Vercammen A. PhD Thesis: Cognitive and neural processes of auditory-verbal hallucinations in schizophrenia, page 123-142. (http://irs.ub.rug.nl/ppn/321676343) Vercammen A., Knegtering H., den Boer H., Liemburg E., Aleman A (2009). Functional connectivity of the tempororparietal regions in schizophrenia: associations with auditory-verbal hallucinations and modulations induced by rtms treatment. In: Vercammen A. PhD Thesis: Cognitive and neural processes of auditory-verbal hallucinations in schizophrenia. page 143-164. (http://irs.ub.rug.nl/ppn/321676343). Vercammen A., Knegtering H., Bruggeman R., Westenbroek JM., Jenner JA., Slooff CJ., Wunderink L., Aleman A (2009). Effects of bilateral repetitive Transcranial Magnetic Stimulation (rtms) on treatment resistant auditory-verbal hallucinations in schizophrenia: a randomized controlled trial. Schizophrenia Research 114 (1-3): 172-179. Hoekert M (2009). Beyond what is being said. Emotional prosody: its neural basis and its relevance for schizophrenia. PhD Thesis, University of Groningen, The Netherlands. (http://irs.ub.rug.nl/ppn/322522269). (Supervision A. Aleman (promoter), H. Knegtering (copromotor). Hoekert M., Vercammen A., Kahn R., Knegtering, H., Aleman A (2009). Abarrant attribution of emotional salience to neutral vocal and facial expressions predicts symptomatology in schizophrenia patients. In: Hoekert M (2009). Beyond what is being said. Emotional prosody: its neural basis and its relevance for schizophrenia. PhD Thesis, University of Groningen, The Netherlands. Page 89-93. (http://irs.ub.rug.nl/ppn/322522269). Hoekert M., Scholten M.R.M., Vercammen A., Kahn R.S., Knegtering H., Aleman A (2009). The relation between impaired prosody perceptin and symptom dimensions in schizophrenia. In: Hoekert M (2009). Beyond what is being said. Emotional prosody: its neural basis and its relevance for schizophrenia. PhD Thesis, University of Groningen, The Netherlands. Page 77-88. (http://irs.ub.rug.nl/ppn/322522269). 2008 Duisterwinkel G., Bosker F.J., Scholte-Stalenhoef A.N., Vervoort M., Knegtering H. (2008). Antipsychotic augmentation strategies to ameliorate negative and cognitive symptoms in schizophrenia. Central Nervous System Agents in Medical Chemistry. Vol 8 No 1. 10-25. Knegtering H., van den Bosch R.J., Castelein S., Bruggeman R., Sytema S., van Os J. (2008). Are sexual side effects of prolactin-raising antipsychotics reducible to serum prolactin. Psychoneuroendocrinology 2008 Jul;33(6):711-7. Castelein S., Bruggeman R., van Busschbach J.T., van der Gaag M., Stant A.D., Knegtering H., Wiersma D. (2008). The effectiveness of peer support groups in psychosis. A Randomised controlled trial. Act Psych Scan, 118: 64-72. Knegtering H., Bruggeman R., Verkes R.J. (2008). Naar een balans tussen gewenste en ongewenste effecten van antipsychotica. (Toward a balance between desired and undesired treatment effects of antipsychotics) In: Verkes R.J., Bruggeman, R (eds). Keuzecriteria voor antipsychotica. Van Zuiden Communications BV, Alphen a/d Rijn. ISBN 978-90-8523-158-5. pp. 35-60 Knegtering H., Bruggeman R. (2008). Het meten van effecten van behandeling. (Evaluation of treatment effects) In: Verkes R.J., Bruggeman R (eds). Keuzecriteria voor antipsychotica. Van Zuiden Communications BV, Alphen a/d Rijn. ISBN 978-90-8523-158-5. pp. 83-90. Knegtering H., Bruggeman R. (2008). Farmacotherapie van psychosen, een handleiding voor de praktijk (Pharmacotherapy of psychotic disorders, a guideline for daily practice). In: Verkes R.J., Bruggeman. Keuzecriteria voor antipsychotica. Van Zuiden Communications BV, Alphen a/d Rijn. ISBN 978-90-8523-158-5. pp 91-108. Smid HGOM., De Witte MR., Bruggeman R., Knegtering H., van den Bosch RJ (2008). Impairment of switching the focus of attention in recent onset schizophrenia. (Submitted June 2008 to Journal of Psychiatry and Neuroscience). Castelein S., Bruggeman R., van Busschbach J.T., van der Gaag M., Stant A.D., Knegtering H., Wiersma D. (2008). Het effect van lotgenotengroepen voor mensen met een psychose; een multi-centre-rct (The effectiveness of peer support groups in psychosis. A multi-center RCT). Voorjaarscongres Nederlandse Vereniging voor Psychiatrie (Annual Spring Congress of the Dutch Psychiatric Association). Tijdschrift voor Psychiatrie 50 (suppl1) S333-334.

Castelein S., Bruggeman R., van Busschbach J.T., van der Gaag M., Stant A.D., Knegtering H., Wiersma D. (2008). The effectiveness of peer support groups in psychosis: a randomized controlled trial. Schizophrenia Research 102/1-3 suppl 2, 253. Knegtering H., Bous, J., Sytema S., Wiersma D. (2008). Risperidon, aripiprazole en seksueel functioneren. (Risperidone, aripiprazole and sexual performance). Voorjaarscongres Nederlandse Vereniging voor Psychiatrie. Poster on the Annual Spring Congress of the Dutch Psychiatric Association. Tijdschrift voor Psychiatrie 50 (suppl1) S335. Knegtering H., van den Bosch R.J., Castelein S., Bruggeman R., Sytema S., van Os J. (2008). Are sexual side effects of prolactin-raising antipsychotics reducible to serum prolactin. First Schizophrenia International Research Society Conference. Venice June 21/25. Schizophrenia Research 102/1-3 suppl 2, 239. De Lange J, Kuipers M, Knegtering H. (2008). Does the Critical Flicker Fusion Threshold distinguish patients with schizophrenia from healthy controls? First Schizophrenia International Research Society Conference. Venice June 21/25. Schizophrenia Research 102/1-3 suppl 2, 106-107. De Lange J, Knegtering H, Aleman A (2008). Rapid Transcranial Magnetic Stimulation (r-tms) for negative and cognitive symptoms in schizophrenia, a meta-analyses. Oral presentation at the First Schizophrenia International Research Society Conference. Venice June 21/25. Schizophrenia Research 102/1-3 suppl 2, 33-34. Wunderink A., Nienhuis F., Sytema SW., Slooff C., Knegtering H., Wiersma D (2008). Guided discontinuation versus maintenance treatment in remitted First episode psychosis: relapse rates and functional outcome. Oral presentation at the First Schizophrenia International Research Society Conference. Venice June 21/25. Schizophrenia Research 102/1-3 suppl 2, 52-53. Knegtering H., Bous, J., Sytema S., Wiersma D. (2008). A randomized open-label comparison of the impact of aripiprazole versus risperidone on sexual functioning (RAS study). Poster on the Annual Spring Congress of the Dutch Psychiatric Association and on the First Schizophrenia International Research Society Conference. Venice June 21/25. Schizophrenia Research 102/1-3 suppl 2, 238. Klein R., Doorduin J., Knegtering H., de Groot JC., Dierckx RA., de Vries EFJ (2008). Profound inflammatory response in the CNS of psychotic patients. Schizophrenia Research 102/1-3 suppl 2, 201. 2007 Knegtering H., Bruggeman R (2007). What are the effects of antipsychotics on sexual functioning? Primary Psychiatry 14(2), 51-56. Wunderink L., Nienhuis F.J., Sytema S., Slooff C.J., Knegtering H., Wiersma D (2007). Guided discontinuation versus maintenance treatment in remitted first episode psychosis: relapse rates and functional outcome. The Journal of Clinical Psychiatry 68;5:654-661. Wunderink L., Nienhuis F.J., Sytema S., Slooff C.J., Knegtering H., Wiersma D (2007). Guided discontinuation versus maintenance treatment in remitted first episode psychosis: relapse rates and functional outcome. In: Antipsychotic treatment strategies and early course of first episode psychosis, PhD Thesis Lex Wunderink 81-100. Bruggeman R., Slooff C.j., Taxis K., Knegtering H., Delespaul P., The Phamous-workgroup. De Pharmacotherapy Monitoring and Outcome Survey: Phamous, opzet en eerste resultaten (Pharmacotherapy Monitoring and Outcome Survey: PHAMOUS, design and first results). Voorjaarscongres Nederlandse Vereniging van Psychiatrie, Maastricht 12 April 2007. Annual Spring Congress of The Dutch Psychiatric Society. Abstract book pages S 107-110. Knegtering H., Bruggeman R (2007). Sexual dysfunction and antipsychotics how to bring up the issue when talking to your patients. Advances in schizophrenia and clinical psychiatry, Vol 3 No 1: 8-12. Knegtering H (2007). Negative and Cognitive Symptoms in Schizophrenia, research and treatment. Doorwerth, Annual Dutch Endo-Neuro-Psycho Meeting. Abstract book page 108. Knegtering, H., Bruggeman, R., Castelein, S., Wiersma D. (2007A). Antipsychotica en seksueel functioneren in mensen met een psychotische stoornis (Antipsychotics and sexual functioning in persons with psychosis). Tijdschr Psychiatr. 2007;49(10):733-42. Knegtering, H., & Bruggeman, R. (2007B). What are the effects of antipsychotics on sexual functioning. Primary Psychiatry febr;14(2):51-56. Knegtering H., Bous J., Sytema S., Wiersma D (2007). A randomized open-label comparison of the impact of aripiprazole versus risperidone on sexual functioning (RAS study). Report made by the research team of The University Medical Centre of Groningen for Brystol-Meyers Squibb. December 8 2007.

Moolen van der A.E.G.M., Bruggeman R., Knegtering H (2007). Overdracht; over voorlichting in de psychiatrie: van theorie naar praktijk (About Health Education in Psychiatry). Boek geschreven in opdracht van afdeling psychosen Universitair Medisch Centrum Groningen (Book written for the department of psychiatry of the University Medical Center in Groningen), ISBN/EAN 978-90- 9032673-6. Castelein S., Bruggeman R., Busschbach van J., van der Gaag M., Stant D., Knegtering H., Wiersma D (2007). The effectiveness of peer support groups in psychosis: a randomized controlled trial effect of peer support groups in psychosis. Schiz Bull submitted. Kemperman R.F.J., Veurink M., van der Wal T., Knegtering H., Bruggeman R., Fokkema M.R., Kema I.P., Korf J., Muskiet F.A.J. Low essentail fatty acid and B-vitamin status in a subgroup of patients with schizophrenia and its response to dietary supplementation. In: Nutitrion and biomarkers in psychiatry. Kemperman R.F.J. 2007. PhD Thesis ISBN 978-90-367-3220-8 (electr. vers. 978-90-367-3221-5). p. 101-120. Kemperman R.F.J. Gouverneur B.J.G.M. Hoekstra Y.T.A., Bruggeman R., Knegtering H., Muskiet F.A.J. (2007). Relations between nicotinate-induced skin flush, erythrocyte fatty acids, serum phospholipase A2 activity and psychopathology in patients with schizophrenia. Poster International Federation of Clinical Chemistry. Hoekstra Y.T., Gouverneur B., Kemperman R., Bruggeman R., Knegtering H., Muskiet F (2007). Niacin skin flush and erythrocyte fatty acid composition in patients with schizophrenia related psychosis. Poster, International Congress on Schizophrenia Research, Colorado Springs. Schizophrenia Bulletin Vol 33 No 2. 218. Wunderink L., Nienhuis F.J., Sytema S., Slooff C.J., Knegtering H., Wiersma (2007). Guided Discontinuation versus maintenance treatment in remitted first episode psychosis: relapse rates and functional outcome. Poster, International Congress on Schizophrenia Research, Colorado Springs. Schizophrenia Bulletin Vol 33 No 2. 466. Knegtering H., Wolters H., Wiersma D (2007). Antipsychotics and quality of life, something to worry about? Poster, International Congress on Schizophrenia Research, Colorado Springs. Schizophrenia Bulletin Vol 33 No 2. 473-474. 2006 Knegtering H. Boks M., Blijd C., Castelein C., van den Bosch RJ (2006). A randomized open-label comparison of the impact of olanzapine versus risperidone on sexual functioning. J. Sex Marital Ther 32(4):315-326. Wolters HA., Knegtering H., Wiersma D., van den Bosch, RJ (2006). The evaluation of the Subjects Reaction to Antipsychotics (SRA) questionnaire. Int Clin Psychopharmacol. 21(1):63-9. Kemperman RFJ., Veurink M., van der Wal T., Knegtering H., Bruggeman R., Fokkema MR., Kema IP., Korf J., Muskiet FAJ (2006). Low essential fatty acid and B-vitamin status in a subgroup of patients with schizophrenia and its response to dietary supplementation. Prostaglandines, Leukotrienes and Essential Fatty Acids. Feb;74(2):75-85. Bruggeman R., Laar van T., Knegtering H (2006). De rol van neurotransmitters bij het ontstaan van hallucinaties (The role of neurotransmitters in the origin of hallucinations). In: Jenner J.A. Hallucinaties, kenmerken, verklaringen behandeling. Koninklijke Van Gorcum, Assen, pp 49-56. Bruggeman R., Knegtering H (2006). Medicamenteuze behandeling van hallucinaties (Pharmacological treatments options in hallucinations). In: Jenner J.A. Hallucinaties, kenmerken, verklaringen behandeling. Koninklijke Van Gorcum, Assen, pp 156-158. Zempleni M., Bruggeman R., Knegtering H., van den Bosch R., Stowe L (2006). Comprehension of idiomatic and non-idiomatic sentences in schizophrenia: results of a pilot fmri study. In: Monika Z. Zempleni,. Functional imaging of the hemispheric contribution to language processing. PhD Thesis, University of Groningen, 83-107. Bosveld van Haandel L., Knegtering H., Kluiter H., van den Bosch RJ (2006). Niacin skin flushing in schizophrenic and depressed patients and healthy controls. Psychiatry Research. 143(2-3): 303-306. Knegtering, H. Gewenste en ongewenste effecten van antipsychotica: Lezing Parnassia Den Haag, februari 2006. Knegtering H. Dwangmedicatie bij psychosen, tussen dwaling en doelmatigheid. Lezing voorjaarcongres Nederlandse Vereniging voor Psychiatrie, 6 april 2006. Wunderink A, Nienhuis J.J., Sytema S., Slooff C.J., Knegtering H., Wierma D. Targeted treatment revisited: een RCT bij eerste psychosen. Uitkomsten en implicaties van de MESIFOS studie. Lezing voorjaarcongres Nederlandse Vereniging voor Psychiatrie, 6 april 2006. Knegtering H., Bruggeman R. Psychofarmacotherapie bij negatieve en cognitieve symptomen. Lezing

voorjaarcongres Nederlandse Vereniging voor Psychiatrie, 5 april 2006. Wolters H.A., Knegtering H., Wiersma D., Bruggeman R. De SRA-q vragenlijst als hulpmiddel bij het afwegen van voor- en nadelen van antipsychotica: van effectivity naar effectiveness. Lezing voorjaarcongres Nederlandse Vereniging voor Psychiatrie, 5 april 2006. Castelein S., Bruggeman R., Busschbach J.T., Mulder P.J., Gaag van der M., Knegtering H., Wiersma D. Effectiviteit van lotgenotengroepen voor mensen met een psychose. Lezing voorjaarcongres Nederlandse Vereniging voor Psychiatrie, 5 april 2006. Knegtering H. Farmacologie en patiënten perspectief. Universitair Medisch Centrum Nijmegen 15-11- 2006. Knegtering H. Gewenste en ongewenst effecten van antipsychotica vanuit farmacologisch perspectief, focus op seksuele functiestoornissen. 8-11-2006 AMC/De Meren Amsterdam. Knegtering H. Gewenste en ongewenst effecten van antipsychotica vanuit farmacologisch perspectief. 7-12-2006 Mentrum Amsterdam. Castelein S., Bruggeman R., Busschach van J.T., Gaag van der M., Knegtering H., Wiersma D (2006). The effectiviveness of professionally guided self-help groups: a multi-center randomized controlled trial. Schiz Res Vol 81. Suppl. 102. Knegtering H, De Hert M., Scholte-Stalenhoef A., Werf-Elderink van der M (2006). Schortterm and longterm effects of antipsychotics on prolacin. Schiz Res Vol 81. Suppl. 136. Knegtering H, De Hert M., Scholte-Stalenhoef A., Werf-Elderink van der M (2006). Prolactin levels during shortterm and longterm antipsychotic treatment. Schiz Res Vol 81. Suppl. 137. Zempleni M.Z., Bruggeman R., Knegtering H., Velzen van M., Bosch van den R.J., Stowe L.A (2006). Comprehension of idioms in schizophrenia, preliminary fmri results. Schiz Res Vol 81. Suppl. 154. Knegtering H., Telleman L., Ouwehand J., Crom G., Bruggeman R., Wunderink L., Douwes A., Wiersma D (2006). Caregivers distress and their appraisal of psychoeducation in patients with a first psychotic episode. Schiz Res Vol 81. Suppl. 240. Wunderink A., Nienhuis F.J., Sytema S., Slooff C.J., Knegtering H., Wiersma D (2006). Targeted treatment revisited: results of a RCT in first episode psychosis. Schiz Res Vol 81. Suppl. 255. Wolters H.A., Knegtering H., Wiersman D., Bosch van den R.J (2006). The quest for quality of life: Subjects Response to Antipsychotics or Symptoms. Schiz Res Vol 81. Suppl. 299. Schorr G.S., Bruggeman R., Knegtering H, Janssen R.A., Brouwers J.R.B.J. Taxis K. (2006). Pharmacotherapy with antipsychotics: a monitoring and outcome survey (PHAMOUS)- preliminary results. Kennisceuntrum schizofrenie congres Zwolle. 2005 Boks MPM (2005). Neurological soft signs in schizophrenia and mood disorders: investigating a potential endophenotype. PhD Thesis University of Groningen, The Netherlands. (http://irs.ub.rug.nl/ppn/28685211x). (Supervision D. Wiersma (promotor), R.J. van den Bosch (promotor), H. Knegtering (co-promotor). Kemperman R., Veurink M., van der Wal T., Knegtering H., Bruggeman R., Fokkema MR., Kema IP., Korf J., Muskiet FA. (2005). Essential fatty acid and b-vitamin status in schizophrenia. Schizophrenia Bulletin 31(2):251. Smid HG., Bruggeman R., Knegtering H., van Burgel J., van den Bosch RJ (2005). Schizophrenia symptoms, schizotypy, vulnerability factors and cognitive efficacy in first onset schizophrenia patients and healthy controls. Schizophrenia Bulletin 31(2):377. Castelein S., Bruggeman R., van Busschbach JT., van der Gaag M., Mulder PJ., Knegtering H., Wiersma D. (2005). Schizophrenia Bulletin 31(2):512-522. Wolters H., Knegtering H., Wiersma D., van den Bosch RJ. (2005). Quality of life and patients evaluation of antipsychotic medication. Schizophrenia Bulletin 31(2):573-574. Knegtering H., Wolters HA., Bruggeman R., van den Bosch RJ., Wiersma D. (2005) The subjects responses to antipsychotics evaluator: SRAe. Schizophrenia Bulletin 31(2):565. Knegtering H., Baselmans P., Castelein S., Bosker F., Bruggeman R., Bosch van den RJ (2005). The 9-OH-metabolite of risperidone has a predominant role in elevating blood prolactin levels. Am J Psychiatry. 162(5):1010-1012. Rijcken CA., Knegtering H., Bruggeman R., Tobi H., de Jong-van den Berg LT. (2005). Sex differences in concomitant medication with benzodiazepines or antidepressants in first-break schizophrenic patients treated with antipsychotic medication. Psychiatry Res. 2005 Apr 15;134(2):143-50. Wolters HA., Knegtering H (2005). Frequentie en ernst van ongewenst effecten bij antipsychotica gebruik (Frequency and burden of undesired effects of antipsychotics). In: Slooff CJ., Withaar

F., van der Gaag M (Editors). Terugvalpreventie bij schizofrenie en verwante psychosen. Uitgave kenniscentrum schizofrenie (Relapse prevention in schizophrenia and related psychosis). Pagina 121-139. Knegtering H., Bruggeman R., Castelein S (2005). Antipsychotica en seksueel functioneren bij mensen met psychotische stoornissen (Antipsychotics and sexual functioning in people with psychosis). In: Slooff CJ., Withaar F., van der Gaag M (Editors). Terugvalpreventie bij schizofrenie en verwante psychosen (Relapse prevention in schizophrenia and related psychosis). Uitgave kenniscentrum schizofrenie. Pagina 177-189. Knegtering H., Bloemendaal M., Bokern H., Dethmers M., Dijkslag C., Joanroy S., Kamphuis R., Klein H., Noppers A., Vels G., Verster M., Raaijmakers C. (2005). Zorgprogramma Psychotische Stoornissen Groningen, een update. Gewijzigde versie eindrapport van de Taakgroep Zorgprogramma Psychotische Stoornissen (Report on a district treatment programm for psychotic disorders). http://ggz.tmlcdns.nl/uploads/psychotische%20stoornissen.doc. Knegtering H., Bruggeman R. (2005). Meetinstrumenten bij psychotische stoornissen. In: Editor: Wunderink. L. Schizofrenie deel 2, diagnostiek en behandeling. Mark Two Communications bv. ISBN 90 77585 34 6. 2004 Kemperman R.F.J.,Veurink M., van der Wal T., Knegtering H., Bruggeman R., Fokkema M.R., Kema I.P., Korf J.,Muskiet F.A.J (2004). Essential fatty acid and B-vitamin status in schizophrenia. Poster Spring Congress Dutch Psychiatric Association. Knegtering, H., Castelein, S., Bous, J., Linde van der, J., Bruggeman, R., Kluiter, H., and Bosch van den, RJ. (2004) Randomized Open-Label Study of the Impact of Quetiapine versus Risperidone on Sexual Functioning. J Clin Psychopharmacology Vol 24 Number 1 Febr pp. 1-6. Boks MP., Liddle PF., Burgerhof JG., Knegtering H., Bosch RJ. (2004) Neurological soft signs discriminating mod disorders from first episode schizophrenia. Acta Psychiatr Scan. 110(1) pp.29-35. Knegtering H.,Bruggeman R., Castelein S (2004). Antipsychotica en seksueel functioneren in mensen met schizofrenie (Antipsychotics and sexual functioning in people with schizophrenia). Tijdschrift voor seksuologie Vol 28,3:140-147 Knegtering H., Bruggeman R (2004). Meetinstrumenten bij psychosen (Instruments evaluating psychosis).tijdschrift voor Psychiatrie Vol 10. 675-681. Knegtering H., Kluiter H (2004). Werken de nieuwe-generatie antipsychotica beter dan de oudere antipsychotica bij schizofrenie of schizoaffectieve stoornis? (Are the newer antipsychotics more effective than the older ones in the treatment of schizophrenia or schizoaffective disorder?). Maandblad Geestelijke volksgezondheid, Vol 9. 747-751. Wolters, H.A., Knegtering, H., Wiersma, D., van den Bosch, R.J.(2004). A Valid and reliable instrument for measuring the subjective response to antipsychotic medication. Schiz Res Vol 67 No 1 suppl. 193. Knegtering, H., Bosveld-van Haandel, L.J.M., Kluiter,H., Bruggeman,R., Castelein,S., van den Bosch, R.J. ( 2004). Is the niacin skin flushing test a tool in the diagnosis of schizophrenia? Schiz Res Vol 67 No 1 suppl. 120. Bruggeman, R., Kamphuis, J.R., Castelein, S., Knegtering, H.(2004). Do atypical antipsychotics differentially affect bone mineral density? Schiz Res Vol 67 No 1 suppl. 181. Castelein, S., Knegtering, H., Beintema, H., Dost, S., Klene, M., Drenth, B., van den Bosch, R.J., (2004). The long-term effects of depot antipsychotics or clozapine on sexual functioning. Schiz Res Vol 67 No 1 suppl. 181. Knegtering H., Bloemendaal M., Bokern H., Dethmers M., Dijkslag C., Joanroy S., Kamphuis R., Klein H., Noppers A., Vels G., Verster M., Raaijmakers C. (2004). Eindrapport van de Taakgroep Zorgprogramma Psychotische Stoornissen (Report on a district treatment programm for psychotic disorders). 2003 Bruggeman, R., Knegtering, H., Baselmans, PC., Bous, J., and Castelein, S., 2003. Differential effects of 9-OH-risperidone on prolactin elevation; an indicator for drug monitoring? Schizophrenia Research. Vol 60. No. 1 Special Issue pp. 309-310. Castelein, S., Bruggeman, R., Mulder, PJ., and Knegtering, H., 2003. Usefulness of semi-structured support groups in schizophrenia. Schizophrenia Research. Vol 60. No. 1 Special Issue pp. 320-321. Boks MP., Liddle PF., Russo S., Knegtering H., Bosch RJ. (2003) Influence of antipsychotic agents on

neurological soft signs and dyskinesia in first episode psychosis. Psychiatry Res 15;119(1-2):167-170. Bous, J., Castelein, S., Kluiter, H., Testke, A., and Knegtering, H., 2003. The antipsychotics and sexual functioning questionnaire (ASFQ): a pilot study evaluating reliability and validity in patients treated with antipsychotics. Schizophrenia Research. Vol 60. No. 1 Special Issue pp. 353. Knegtering, H., Castelein, S., Linde van der, J., Bous, J., Bruggeman, R., and Bosch van den, RJ., 2003. Sexual dysfunctions and prolactin levels in patients using classical or modern antipsychotics. Schizophrenia Research. Vol 60. No. 1 Special Issue pp. 358-359. Wolters, HA., Knegtering, H., Wiersma, D., and Bosch van den, RJ., 2003. Experiences of patients with antipsychotic medication: a questionnaire. Schizophrenia Research. Vol 60. No. 1 Special Issue pp. 370. Knegtering, H., Slooff, CJ., Bruggeman, R., Arends, J., Withaar, F., and Wolff, H. (2003) Behandelprotocollen bij schizofrenie en verwante psychosen (treatment protocols in schizophrenia and related psychotic disorders). Kenniscentrum Schizofrenie, Groningen-Assen- Den Haag, Schizofreniestichting Nederland, Koninklijke van Gorkum ISBN 90 232 3885 0. Knegtering H., Melman, CTM. (2003) A flexible dose trial with risperidone in early psychotic patients (RIS-NED 16), report for Janssen-Cilag. Wolters HA., H. Knegtering, D. Wiersma, R. J. van den Bosch (2003). The spectrum of subjective effects of antipsychotic medication. Acta Neuropsychiatrica. Vol 15(5) pp: 274-279. Knegtering H. Antipsychotic treatment and sexual functioning, role of prolactin. Proefschrift Universiteit Groningen (Ph.D thesis University of Groningen, The Netherlands). http://irs.ub.rug.nl/ppn/254939104 Rijcken CAW., Knegtering H., Westerink BHC, Berg van den PB., Tobi H., Jong de Berg van den LTW. The estrogen hypothesis extrapolated: what drug-utilistation studies can add to the theory. In: Claudia Rijcken: Pharmamacy data as tool for assessing antipsychotic drug use. Proefschrift Universiteit Groningen (Ph.D thesis University of Groningen, The Netherlands) pp. 45-56. http://dissertations.ub.rug.nl/files/faculties/science/2003/c.a.w.rijcken/ Rijcken CAW., Knegtering H., Bruggeman R., Tobi H., Jong de Berg van den LTW. (2003) Concomitant psychotrophic drug use among first-break patients with schizophrenia: the sex differences. In: Claudia Rijcken: Pharmamacy data as tool for assessing antipsychotic drug use. Proefschrift Universiteit Groningen (Ph.D thesis University of Groningen, The Netherlands) pp. 71-83. (Psychiatry Research, in press) http://dissertations.ub.rug.nl/files/faculties/science/2003/c.a.w.rijcken/ Rijcken CAW., Dekens-Konter JAM., Knegtering H., Bruggeman R., Jong de Berg van den LTW. (2003) Reporting sexual function disorders caused by antipsychotic drugs: is there a role for the community pharmacy? In: Claudia Rijcken: Pharmamacy data as tool for assessing antipsychotic drug use. Proefschrift Universiteit Groningen (Ph.D thesis University of Groningen, The Netherlands). http://dissertations.ub.rug.nl/files/faculties/science/2003/c.a.w.rijcken/c9.pdf Rijcken CAW., Veur van der H., Knegtering H., Jong de Berg van den LTW. (2003) Schizophrenia care and the dutch community pharmacy: the unmet needs. In: Claudia Rijcken: Pharmamacy data as tool for assessing antipsychotic drug use. Proefschrift Universiteit Groningen (Ph.D thesis University of Groningen, The Netherlands) pp. 99-115. (Int J of Pharmacy Practice 2003,6.). http://dissertations.ub.rug.nl/files/faculties/science/2003/c.a.w.rijcken/ Holthausen EAE., Wiersma D., Knegtering H., Bosch van den RJ. (2003) Psychopathology and cognition in schizophrenia spectrum disorders: the role of depressive symptoms. In: Esther Holthausen. Cognition in recent onset schizophrenia. Proefschrift Universiteit Groningen (Ph.D thesis University of Groningen, The Netherlands) pp. 81-94 Gaag van der M., Faber G., Knegtering H. (2003) Schizophrenia Research, verslag van de International Conference on Schizophrenia Research (Congress review), Verenigde Staten, 30 Maart t/m 2 april 2003. Maandblad Geestelijke Volksgezondheid, nr 10. pp. 961-965. Knegtering H., Bruggeman R. (2003) Welk (depot) neurolepticum is een goede keus bij een chronisch psychotische patiënt met epilepsie die fenytoine en carbamazepine gebruikt? (Which antipsychotic medication is a good choice in patients with a chronic psychotic illness and epilepsy being treated with fenytoine and carbamazepine?). Apothekers Vademecum, Nummer 3. Knegtering H., van der Moolen AE, Castelein S., Kluiter H., van den Bosch R.J. (2003). What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning? Psychoneuroendocrinology. 2003 Apr;28 Suppl 2:109-23. Review.

2002 Knegtering, H., Castelein, S., Linde van der, J., and Bous, J., 2002. Sexual dysfunctions and serum prolactin levels in patients using risperidone or quetiapine: a randomised trial. Schizophrenia Research. Vol 53. No 3. Special Issue pp. 163. Knegtering, H., Castelein, S., Linde van der, J., and Bous, J., 2002. Sexual dysfunctions and antipsychotics. Schizophrenia Research. Vol 53. No 3. Special Issue pp. 167. Holthausen, EAE., Wiersma, D., Knegtering, H., and Bosch van den, RJ., 2002. Does cognition predict outcome and course of illness in schizophrenia? Schizophrenia Research. Vol 53. No 3. Special Issue pp. 127. Holthausen, EAE., Wiersma, D., Knegtering, H., and Bosch van den, RJ., 2002. Are long-term memory deficits a primary dysfunction in schizophrenia? Schizophrenia Research. Vol 53. No 3. Special Issue pp. 130. Wolters, HA., Knegtering, H., Wiersma, D., and Bosch van den, RJ., 2002. A questionnaire for patients evaluation of antipsychotic medication. Schizophrenia Research. Vol 53. No 3. Special Issue pp. 301. Castelein, S., Jong de, A., Mulder, PJ., Bruggeman, R., and Knegtering, H., 2002. Fellow-sufferers: a support-group for young people suffering from psychosis. Schizophrenia Research. Vol 53. No 3. Special Issue pp. 260. Wolters, HA., Knegtering, H., Wiersma, D., and Bosch van den, RJ., 2002. Subjective reactions on antipsychotics. Poster, spring congress Dutch Psychiatric Association. Congress-book 187-188. Castelein, S., Mulder, PJ., Jong de, A., Bruggeman, R., and Knegtering, H., 2002. Are supportgroups for people with a psychosis, useful? Poster, spring congress Dutch Psychiatric Association. Congress-book 188-189. 2001 Knegtering, H., Boks, M., Blijd, C., Wiersma, D., and Bosch van den, RJ., 2001. Sexual dysfunctions in patients using risperidone or olanzapine: a randomized trial. Schizophrenia Research. 49 (NOS 1-2 supplement):285. Castelein, S., Boks, M., Jong de, P., Bruggeman, R., Knegtering, H., and Bosch van den RJ., 2001. Obstetric complications and neurological soft signs in patients with schizophrenia. Schizophrenia Research. 49 (NOS 1-2 supplement):22-28. Holthausen, EAE., Wiersma, D., Knegtering, H., and Bosch van den, RJ., 2001. Compensation of neurocognitive deficits: influence on course of illness in schizophrenia. Schizophrenia Research. 49 (NOS 1-2 supplement):109. Wolters, HA., Knegtering, H., Wiersma, D., and Bosch van den, RJ., 2001. Patients experiences with antipsycotic medication. Schizophrenia Research. 49 (NOS 1-2 supplement): 291. Rijcken, CAW., Dekens-Konter, JAM., Knegtering, H., and Jong de-berg van den, LTW., 2001. Reporting sexual function disorders caused by antipsychotic drugs: is there a role for the community pharmacy? Pharmacy, World and Science. 23(5):169-172. Rijcken, CAW., Knegtering, H., Bruggeman, R., and Jong de-berg van den, LTW., 2001. Observational follow-up study of a cohort of antipsychotic users: are there sex differences in comedication in first-psychosis? Pharmaco-epidemiology and Drug Safety.10:S60. Huusen, EM., Knegtering, H., Slooff, CJ., and Kappert, J., 2001. Atypical antipsychotics and weight gain: incidence, ethiology and treatment modalities. Acta Neuropsychiatrica. Vol. 13, no 4, 91-99. 2000 Knegtering, H., Bruggeman, R., and Wolff, H., 2000. Behandelprotocollen bij schizofrenie en verwante psychosen. (Treatment protocols in schizophrenia an related psychotics disorders; Chapter in a book on psychopharmocology) In: A.J.L.M. van Balkom, P.N. van Harten, P. Kölling, P. Moleman. Behandeling met psychofarmaca: voorbeelden uit de dagelijkse praktijk. Bohn Stafleu van Loghum Houten/Diegem pp.120-150 Knegtering, H., Blijd, C., Boks, MPM., 2000. Sexual dysfunctions and prolactin levels in patients using risperidone or olanzapine. Schizophrenia Research. Vol 41 No 1,196. Holthausen, EAE., Wiersma, D., Knegtering, H., and Bosch van den, RJ., 2000. Do schizophrenic patients without neuropsychological deficits still show signs of cognitive decline? Schizophrenia Research. Vol 41 No 1, 269. Knegtering, H., Lambers, PA., Prakken, G., and Brink ten, C., 2000. Serum prolactin levels and sexual dysfunctions in antipsychotic medication, such as risperidone: a review. Acta Neuropsychiatrica.

Vol 12 No 1, 19-26. Boks, MPM., Knegtering, H., Haaxma, R., and Bosch van den, RJ. et al, 2000. The specificity of neurological signs in schizophrenia: a Review. Schizophrenia Research. 43/2-3, 109-115 Knegtering, H., Boks, MPM., Blijd, C., Wiersma, D., and Bosch van den, RJ., 2000. Sexual dysfunctions in patients on antipsychotics. Syllabus & Proceedings Summary, America Psychiatric Association, 2000 Annual Meeting. P 90. 1999 and earlier work Gleich van, J., and Knegtering, H., 1999. Minder kanker bij schizofrenie? (Less cancer in schizophrenia?) Tijdschrift voor Psychiatrie. Vol 41, No2, 95-103 Knegtering, H., Blijd, C., and Boks, MPM., 1999. Sexual dysfunctions and prolactin levels in patients using classical antipsychotics, risperidone or olanzapine. Schizophrenia Research. Vol. 36 NOS.1-3, 355-356 Holthausen, EAE., Wiersma, D., Knegtering, H., and Bosch van den, RJ., 1999. Psychopathology and cognition in schizophrenia spectrum disorders: the role of depressive symptoms. Schizophrenia Research. Vol. 39, 65-71. Nolen, WA., and Knegtering, H., 1999. Farmacotherapie bij de manisch depressieve stoornis (Pharmacotherapy in bipolar disorders; Chapter in a book on bipolar disorders) In: Boer den, JA. et al. (Eds). Handboek Stemmingsstoornissen. 232-245. Maarsen: Elsevier/De Tijdstroom. Knegtering, H., Boks, M., and Brink ten, C., 1998. Sexual dysfunction and serum prolactin levels in patients using classical antipsychotics or risperidone. Poster presentation ninth biennial winter workshop on schizophrenia. Schizophrenia Research. Vol 29. NOS 1.2 186. Boks, MPM., Knegtering, H., Haaxma, R., and Bosch van den, RJ., 1998. Neurological signs in patients with a first episode of psychosis and healthy controls. Poster presentation ninth biennial winter workshop on schizophrenia. Schizophrenia Research. Vol 29. NOS 1.2 179-180. Brink ten, C., Haan de, L., and Knegtering, H., 1998. Subjectieve ervaringen van patiënte met schizofrenie gerelateerd aan behandeling met antipsychotica (subjective experiences of patients with schizophrenia related to the use of antipsychotics). Tijdschrift voor psychiatrie. Vol 4. 238-245. Knegtering, H., Boks, MPM., and Brink ten, C., 1998. Gender specific sexual dysfunctions and serum prolactin levels in patients using classical antipsychotics or risperidone. Poster presentation in the Annual congress of the Dutch Psychiatric Association. Knegtering, H., Boks, M., and Brink ten, C., 1997. Sexual dysfunction and serum prolactin level in patients using classical antipsychotics or risperidone. Poster presentation in the Annual congress of the Dutch Psychiatric Association. Boer den, JC., and Knegtering, H., 1997. Tardieve dyskinesie en vitamine E. (Tardive dyskinesia and vitamin E). Tijdschrift voor Psychiatrie. Vol 6. 490-496. Knegtering, H., Boer, JC., Brink ten, C., Pals-Verlinde, AA., Wijngaarden van, P., and Tulner, D., 1996. Schizofrenie en motorische stoornissen (Schizophrenia and motoric disorders) In: Dr. J.A. den Boer, Prof. Dr. R. J. van den Bosch (Red): Leerboek Schizofrenie, een neurobiologische benadering. pp 213-236. Knegtering, H., Moleman, P., Pot, HJ., Slaets, JPJ., and Nolen, WA., 1996. Biologische behandelmethoden bij de manisch-depressieve stoornis. (Biological treatment options in bipolar disorders; Chapter in a book on treatmentstrategies) In: Dr. W.A. Nolen en E. Knoppert. Behandelstrategieën voor manisch depressieve stoornissen. pp 33-49. Verhallen, JTCM., and Knegtering, H., 1996. Meetinstrumenten voor motorische stoornissen (Instruments evaluating motoric disorders). COBO bulletin. Jaargang 29, nummer 1, pp. 36-41. Knegtering, H., Brink ten, C., Boks, M., and Lambert, P., 1996. Classical and atypical antipsychotics and sexual dysfunction in patients with first episode psychosis. In; First Psychotic Episode of Schizophrenia, Congress Abstract Book, Amsterdam. pp. 67. Hoencamp, E., Knegtering, H., Kooy, JJS., and Moolen van der, AEGM., 1995. Patient requests and attitude towards neuroleptics. Nordic Journal of Psychiatry. Volume: 49 Pages: 47-55 Supplement: Suppl. 35 Hoencamp, E., Haffmans, PMJ., Knegtering, H., Duivenvoorden, HJ., and Dijken, WA., 1995. Prediction of (non)response in depressed outpatients treated with moclobemide. Report for Roche. Gernaat, HBPE., Haffmans, PMJ., Knegtering, H., and Birkenhager, TK., 1995. Tranylcypromine in narcolepsy. Pharmacopsychiatry. 28, 98-100 Hoencamp, E., Knegtering, H., Kooy, JSS., and Moolen van der, AEGM., 1995. Patient requests and attitude towards neuroleptics. European Neuropsychopharmacology. Volume 5, Number 3, pp.

337-338. Knegtering, H., Eyck, M., and Huijsman, A., 1994. The effects of antidepressants on cognitive functioning of elderly patients; a review. Drugs and Aging. 5 (3): 192-199. Kooy, JJS., Knegtering, H., and Hoencamp, E., 1994. Behoefte aan zorg en waardering van zorg bij patiënten die oraal neuroleptica gebruiken. Een verkennend onderzoek op de polikliniek van het Psychiatrisch Centrum Bloemendaal te Den Haag, Rapport. (Patient requests and attitude towards neuroleptics, an pilot study in the Psychiatric Hospital of Bloemendaal, The Hague, Report). Hoencamp, E., Haffmans, PMJ., Duivenvoorden, H., Knegtering, H., and Dijken, WA., 1994. Predictors of (non)response in depressed outpatients treated with a three-phase sequential medication strategy. Journal of Affective Disorders. 31, 235-246. Knegtering, H., Haffmans, PMJ., Huisman, A., and Eijck, M., 1994. The effects of fluoxetine on the cognitive functioning of elderly depressed patients. Report for Ely Lilly. Haffmans, J., and Knegtering, H., 1993. The Selective Reversible Monoamine Oxidase-A Inhibitor Brofaromine and Sleep. Journal of Clinical Psychopharmacology. Vol 13/No 4, 291-292. Hoencamp, E., Haffmans, P., Duivenvoorden, H., Knegtering, H., and Dijken, W., 1993. Predictability of (non-)response in depressed out-patients in a three-phase sequential treatment medication strategy. In het Academisch Proefschrift: Depressed out-patients: efficacy and predictability of response of a three-phase treatment strategy. Promovendus Hoencamp, E., Vrije Universiteit Amsterdam. Moolen van der, AEGM., and Knegtering, H., 1993. Behoefte aan zorg en de waardering van zorg. Een exploratief onderzoek op de parkpolikliniek te Rotterdam naar de behoefte aan zorg en de waardering voor de gegeven zorg bij patiënten die depot neuroleptica gebruiken. (Needs for care study in patients using intramuscular depot antipsychotics, report for Lunbeck, The Netherlands). Onderzoek in opdracht van de parkpolikliniek in Rotterdam, gesubsidieerd door Lundbeck, Nederland. Knegtering, H., Eyck, M., Huijsman, A., Hoencamp, E., and Haffmans, J., 1992. The Effects of maprotiline and brofaromine on cognitive performance in elderly depressed patients: A pilot study. Poster voorjaarcongres Nederlandse Vereniging van Psychiatrie 1992. Tijdschrift voor psychiatrie. 218. Haffmans, J., and Knegtering, H., 1991. Sleep items of the HRSD in depressed patients treated with brofaromine. Sleep Research. 20A, 576. Haffmans, J., Hoencamp, E., and Knegtering, H. 1991. Brofaromine in therapy resistant depression. Biol. Psychiatry. 29: 11S:37S Knegtering, H., 1990. De computer en het Diagnostic Interview Schedule. Een onderzoek naar de mogelijkheden om in de psychiatrie gestructureerde interviews, zoals de DIS, met behulp van een computer af te nemen. (A study for possibilities in psychiatry for computer assisted diagnostics especially with the Diagnostical Interview Schedule (DIS), a report). Onderzoeksrapport/eindscriptie psychiatrisch ziekenhuis Veldwijk te Ermelo. Knegtering, H., 1987. The results on the Expanded Programme of Immunisation (EPI) in Southern Darfur (Sudan) Ed Daien. A field survey for MSF-Belgium and the World Health Organisation. Nyala (Sudan). Knegtering, H., 1987. Primary Health Care Rehabilitation. Report concerning the activities of MSF- Belgium in the province of Southern Darfur including an activity report especially for Ed Dain district. A report for Medicins Sans Frontieres-Belgium. Nyala (Sudan). H. Knegtering, MD PhD, Groningen May-2010